What DRS Group does

DRS Group, founded in 1995 and headquartered in São Paulo, Brazil, is a privately held health logistics company providing integrated solutions for pharmaceutical companies, contract research organizations (CROs), research centers, healthcare operators, and logistics partners. The company operates across three complementary service divisions: Clinical Trial Services (CTS), covering comparator sourcing, regulatory-controlled storage, packaging/labeling/blinding, kit assembly, and specialized transport; Patient Centric Services (PCS), covering patient support programs, direct-to-patient delivery, and innovative therapy logistics; and Thermo Integrated Services (TIS), covering reusable high-performance packaging, real-time telemetry, and cold-chain transport with validated ranges from +25°C to -196°C. These divisions are unified by DRS 360, a proprietary digital platform providing real-time geolocation, temperature/humidity/light monitoring, inventory control, configurable smart alerts, compliance audit trails (FDA, EMA, ANVISA, ANMAT), and an Open API for sponsor integration.

The business operates a direct enterprise sales motion with a dedicated commercial team (+55 11 3198-9000) and quote-based, non-publicly disclosed pricing. Reported scale includes +500 protocols under management, +100 active enterprise clients, +115 DRS 360 platform clients, +50,000 clinical kits assembled, 2 million products in validated thermal storage, +40,000 patients served per year, and a 95% rate of deliveries completed within 24 hours. DRS generates revenue through managed services contracts (CTS, PCS), hardware/resuable packaging sales (TIS), and recurring platform subscriptions (DRS 360).

The company maintains multinational operations across Brazil (São Paulo HQ and LATAM logistics center, plus Campinas, Taboão da Serra, Brasília), Uruguay (Montevideo), Argentina (Buenos Aires), and Ireland (Dublin, as DRS International European HQ). Its compliance stack includes ISO 9001:2015, ISO 27001/27017/27701, GDP, ICH-GCP, CEIV Pharma (IATA), LGPD/GDPR/HIPAA, Dangerous Good license, Operador de CAR-T authorization, EcoVadis ESG assessment, and SBTi climate commitments. No funding rounds, M&A, or public-market activity are disclosed; ownership and founder equity are not publicly detailed.

Name

DRS Group

Legal name

DRS Group

Website

https://drsgroup.com.br

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

101–250 employees

Short description

DRS Group is a privately held Brazilian health logistics provider offering integrated clinical trial, patient-centric, and cold-chain services to biopharma, CROs, research centers, and operators, unified by its proprietary DRS 360 traceability platform.

Ownership category

akta.pro rank

Product category

Healthcare Logistics Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (6215)

SIC

Services-Health Services (8000), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Clinical trial logistics
• Cold chain management
• Pharmaceutical distribution
• Patient support services
• Healthcare supply chain

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Clinical Trial Services (CTS): Integrated solutions for clinical studies including comparator drug supply, specialized storage, global import services, packaging/labeling/blinding, laboratory kit assembly and distribution, and specialized transport. Revenue generated through service contracts with pharmaceutical companies, CROs, and research centers for managing clinical trial logistics.
2. Patient Centric Services (PCS): Comprehensive patient support programs, consumer/patient services, innovative therapies support, direct-to-patient delivery, patient kit assembly, and specialized transport. Revenue from pharmaceutical companies and healthcare operators for patient support and adherence programs.
3. Thermo Integrated Services (TIS): Cold chain solutions including reusable high-performance packaging, specialized cold chain transport, import management, and real-time telemetry monitoring. Revenue from temperature-sensitive product logistics contracts.
4. DRS 360 Platform: Digital platform providing real-time tracking, inventory management, smart alerts, and compliance tracking. Platform access for clients to monitor and manage their projects.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

DRS Group provides integrated healthcare logistics solutions connecting pharmaceutical manufacturers, biotech firms, clinical research organizations (CROs), research centers, and healthcare operators. Its offerings include Clinical Trial Services (CTS), Patient Centric Services (PCS), Thermo Integrated Services (TIS) for cold-chain handling, and the proprietary DRS 360 platform that provides real-time monitoring, traceability, and Open API integration across the supply chain.

Product overview

DRS Group operates as a unified health solutions ecosystem organized around one core platform and three complementary service divisions. The proprietary DRS 360 platform serves as the central technology layer providing real-time traceability, inventory management, intelligent alerts, and compliance reporting. Three service sub-brands—Clinical Trial Services (CTS), Patient Centric Services (PCS), and Thermo Integrated Services (TIS)—deliver specialized operational capabilities in clinical research logistics, patient support programs, and cold chain management respectively, all integrated through the DRS 360 platform.

Differentiator

Problem solved

Functional benefit

Brands

• Clinical Trial Services (CTS): Integrated and regulated solutions for clinical studies with full traceability and international compliance, covering comparator drug supply, storage, import, packaging, labeling, blinding, lab kits, and specialized transport.
• Patient Centric Services (PCS)
• Thermo Integrated Services (TIS)
• DRS 360

Products and services

• Clinical Trial Services (CTS)

Quantifiable outcome

• 95% of deliveries made within 24 hours
• +5 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Feature11 records

Partnerships

Two partnerships are on record, tiered minor.

• Shield CompanyminorOthersShield Company is a community partner of DRS Group, listed as part of the DRS ecosystem. The partnership appears to be a community/network association rather than a strategic business partnership.
• YouVitaminorOthersYouVita (youvita.com.br) is a community partner of DRS Group, listed as part of the DRS ecosystem for health community expansion.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Tive: Tive is a supply chain visibility company specializing in real-time IoT sensors and tracking software for cold chain logistics. Emerging player providing adjacent technology (telemetry, real-time monitoring) that competes with DRS 360's tracking capabilities and could be adopted by DRS's competitors or customers, shaping the technology layer of clinical trial logistics.

Direct peers

• World Courier (Cencora): World Courier, part of Cencora (formerly AmerisourceBergen), is a global leader in specialty clinical trial logistics and cold chain distribution. Directly comparable to DRS Group's Clinical Trial Services (CTS) and Thermo Integrated Services (TIS) offerings, serving the same biopharma and CRO customer base with temperature-controlled transport and comparator drug supply.
• Catalent (Novo Holdings): Catalent is a global clinical supply services provider offering comparator sourcing, clinical packaging, labeling, distribution, and return logistics. Directly comparable to DRS Group's CTS offerings for clinical trial material management, with overlap in patient-centric services and cold chain capabilities.
• Marken (UPS Healthcare): Marken, the clinical trial logistics arm of UPS Healthcare, provides global supply chain solutions for the pharmaceutical and life sciences industries including direct-to-patient services. Directly comparable to DRS Group's integrated CTS and PCS service portfolio with similar focus on time- and temperature-sensitive clinical trial materials.
• Biocair: Biocair is a specialist global courier and logistics provider dedicated to the pharmaceutical, biotechnology, and life sciences sectors. Directly comparable to DRS Group's clinical trial logistics and cold chain services, serving similar sponsor and CRO customers with temperature-controlled transport solutions.
• PCI Pharma Services: PCI Pharma Services is a global CDMO and clinical trial services provider offering clinical packaging, labeling, storage, and distribution. Directly comparable to DRS Group's clinical trial packaging, labeling, blinding, and kit assembly capabilities within CTS, serving overlapping biopharma customers.
• Movianto (PHOENIX Group): Movianto, part of the PHOENIX Group, is a European pharmaceutical logistics specialist offering warehousing, distribution, and cold chain services. Comparable to DRS Group's TIS cold chain and CTS storage/distribution operations, particularly relevant given DRS's Dublin European HQ.

Broad incumbents

• Kuehne+Nagel (KN PharmaChain): Kuehne+Nagel operates a dedicated pharma and healthcare logistics offering (KN PharmaChain) covering air, sea, and road freight with GDP-compliant cold chain capabilities. Broad incumbent directly comparable to DRS Group's TIS cold chain and CTS logistics services, with greater global reach and established multinational sponsor relationships.
• DHL Supply Chain (Life Sciences & Healthcare): DHL Supply Chain operates a global Life Sciences & Healthcare vertical providing temperature-controlled logistics, warehousing, and clinical trial distribution. Broad incumbent serving DRS Group's same customer segments with greater scale, broader geographic coverage, and deeper sponsor relationships, representing the principal competitive threat in LATAM expansion.
• Yusen Logistics (Pharma & Healthcare): Yusen Logistics operates a global pharmaceutical and healthcare logistics practice with GDP-certified cold chain solutions across multiple continents. Broad incumbent offering overlapping capabilities with DRS Group's TIS and CTS services, competing for the same biopharma customer base with broader global network and established EU/APAC presence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks1 record

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/results?search_query=DRS+Group+Sa%C3%BAde
• Facebookfacebook.com/GRDRS

Compliance15 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DRS Group